Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals
- PMID: 34384812
- PMCID: PMC8351117
- DOI: 10.1016/j.jinf.2021.08.012
Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals
Comment on
-
Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.04.037. Epub 2021 May 11. J Infect. 2021. PMID: 33989631 Free PMC article.
References
-
- Prevalence of antibodies to SARS-CoV-2 natural infection and post-vaccination in Irish Hospital Healthcare Workers (PRECISE 2) [Internet]. Health Protection Surveillance Centre of Ireland (HPSC); 2021 [cited 2021 Jul 26]. Available from: https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/researc...
-
- CDC morbidity and mortality weekly report (MMWR) - interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers — Eight U.S. locations, December 2020–March 2021 [Internet]. 2021 [cited 2021 Jun 16]. Available from: https://www.cdc.gov/mmwr/volumes/70/wr/mm7013e3.htm - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous